Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy

Read full text
Authors: Shi-Qi Zhou, Lu-Na Wang, Wu Lw, Liyu Sun, Yu-Chen Yang, Zi-Yue Yang, Zi-Yi Wang, He Tian, Fei Li, Ling-Li Chen, Hui Li, Xiao-Dong Zhu
+10 more Ying-Hao Shen, C. Huang, Yuan Ji, Qi Gao, Jian Zhou, Fan Jia, Yuehua Chen, Tian-Qiang Song, B. Xu, HUI-CHUAN SUN
Cited by: 1
References: 33

Abstract

BACKGROUND AND AIMS: Pathological complete response (pCR) following conversion therapy for initially unresectable hepatocellular carcinoma (uHCC) remains challenging to predict preoperatively. This study developed and validated a model integrating clinicopathological and radiomic features of the tumor to predict pCR. METHODS: In this multicenter retrospective study, temporal radiomics features were extracted from baseline, post-treatment, and delta (change) MRIs. Serum AFP response was calculated as log₁₀(preoperative AFP)/log₁₀(baseline AFP). Univariate analysis, collinearity assessment, LASSO, and random forest were employed to perform feature selection. Fourteen machine learning models were benchmarked, with performance evaluated by using comprehensive metrics AUC, NPV, PPV, sensitivity, specificity, calibration, and decision curve analysis. RESULTS: The model was developed and validated in a training (n=78), an internal test (n=32), and an independent validation cohort (n=44). The delta radiomic model significantly outperformed both baseline (test AUC: 0.835 vs. 0.483, p

Fields of Study & Subjects

Radiomics and Machine Learning in Medical Imaging Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
84
Issue
2
Pages
453–468
Publication date
26 February 2026
Language
EN